Suppressive Epitope in Colorectal and Gastric Cancer
Author Information
Author(s): S. Foulds, C.H. Wakefield, M. Giles, J. Gillespie, J.F. Dye, P.J. Guillou
Primary Institution: Imperial College of Science, Technology and Medicine, St Mary's Hospital Medical School
Hypothesis
Does pl5E-related material explain the immunosuppression seen in colorectal and gastric tumors?
Conclusion
The study found that mRNA for pl5E-related material is highly expressed in most human colorectal and gastric cancers, suggesting its role in immune suppression.
Supporting Evidence
- mRNA for pl5E was found in 24 of 30 colorectal cancer samples.
- All four gastric cancer specimens tested positive for pl5E mRNA.
- Non-malignant mucosa rarely showed pl5E mRNA, mostly in inflammatory conditions.
Takeaway
The study looked at cancer samples and found a special material that can make the immune system less effective against tumors.
Methodology
The study involved analyzing mRNA from tumor samples of colorectal and gastric cancer patients and testing synthetic peptides for their effects on immune response.
Limitations
The study did not establish the exact role of the proteins encoded by the identified mRNA in humans.
Participant Demographics
{"colorectal_cancer":{"mean_age":63.5,"male_female_ratio":"20:10","staging":{"Dukes_A":1,"Dukes_B":13,"Dukes_C":11,"Dukes_D":5}},"gastric_cancer":{"mean_age":65.3,"male_female_ratio":"2:2","staging":"All node-positive"}}
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website